Cover
Vol. 12 No. 1 (2022)

Published: June 30, 2022

Pages: 37-54

Research Article

Evaluation of LH level at different time points during the follicular phase in ICSI cycle and correlation with pregnancy.

Abstract

Luteinizing hormone (LH) plays vital role for optimal follicular growth, maturation and is responsible for inducing ovulation, various protocols in ICSI cycles used to prevent the premature surge of luteinizing hormone. Currently, flexible GnRH antagonist protocols appears to be mostly used protocols. individualization of controlled ovarian hyper stimulation (COS) needs better timing of antagonist administration, assessing variation in LH levels during COS helps in determining appropriate initiation of inhibition .This prospective comparative observational analysis was made on one hundred twenty females with infertility who were undergoing ICSI flexible antagonist protocol at the “High Institute for Infertility Diagnosis and Assisted Reproductive Technologies/Al-Nahrain University” from October 2020 to April 2022, primary infertility was the with higher percentage (78.3%) than the secondary type. However; the main cause of infertility among the participant was male type (36.7%) fallowed by the combined one (20.8%). A highly significant difference was present in LH levels at all time points, with level decreasing from 4.99 ± 1.90 at baseline to 4.82± 2.15 at antagonist starting day to 1.63± 0.87 at trigger day and p value was > 0.001, no statistical difference in LH levels regarding the three time points between patients who get pregnant and non-pregnant women with pregnant patients having higher baseline lower antagonist starting day, and higher trigger LH levels 5.16 ± 1.87, 4.30 ± 1.72, 4.30 ± 1.72 respectively. Difference in LH level between cycle day 2 and the day of antagonist starting according to starting day of antagonist reveals that the basal LH values declined significantly (p= <0.001) until cycle day 7 of stimulation after which the basal LH start to increase and also with a high significant difference (negative values mean that the level decrease in comparison to the base line level).The comparable LH level in the current study reveals that earlier initiation of antagonist may serve no purpose and it is advisable to include the measurement of LH level to the criteria of antagonist initiation for better individualization and better outcome and to avoid un necessary earlier start of antagonist.

References

  1. Hattori K, Orisaka M, Fukuda S, Tajima K, Yamazaki Y, Mizutani Y, et al (2018).
  2. Depalo R, Trerotoli P, Chincoli A, Vacca MP, Lamanna G, Cicinelli E. (2018)
  3. Liu M, Liu S, Li L, Wang P, Li H, and Li Luteinizing hormone facilitates antral follicular maturation and survival via thecal paracrine signaling in cattle. Endocrinology 159:2337–47. http://doi.org/doi: 10.1210/en.2018-00123
  4. Kolibianakis, J. Collins, B. Tarlatzis, E. Endogenous luteinizing hormone concentration and IVF outcome during ovarian stimulation in fixed versus flexible GnRH antagonist protocols: an RCT. Int J Reprod Biomed. 16:175–82. http://doi.org/ 10.29252/ijrm.16.3.175 2001. Objective evidence of LH dependence in women with profound LH and FSH deficiency. Fertility and Sterility, 76 (3), p.S208. gynaecology and obstetrics: ovulation induction. The Obstetrician and Gynaecologist 2005;7:66. 10.1576/toag.7.1.066.27047 Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study. Fertil Steril 2016;106:653–9. 10.1016/j.fertnstert.2016.06.002 Y (2019) LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study. Front. Endocrinol. 10:67. Doi: 10.3389/fendo.2019.00067 Papanikolaou, P. Devroey, 2006. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review, Human Reproduction Update, Volume 12, Issue 1, January/February 2006, Pages 3–12
  5. Lv YS, Li Y, Liu S. 2021 Luteinising hormone-based protocol versus traditional flexible gonadotropin-releasing hormone antagonist protocol in women with normal ovarian response: study protocol for a non- inferiority trial. BMJ Open. 2021 Aug 18;11 (8):e047974. doi: 10.1136/bmjopen-2020- 047974. PMID: 34408042; PMCID: PMC8375742.
  6. Bhattacharya, S., Maheshwari, A., & Mollison, J. (2013). Factors Associated with Failed Treatment: an Analysis of 121,744 Women Embarking on Their First IVF Cycles. PLoS ONE, 8 (12), e82249.
  7. Elhussein, O.G., Ahmed, M.A.,
  8. Moyo S. Indigenous knowledge systems and attitudes towards male infertility in Mhondoro-Ngezi, Zimbabwe. Cult Health Sex. 2013;15:667–79 Available from:
  9. Moridi, A., Roozbeh, N., Yaghoobi, H., Soltani, S., Dashti, S., Shahrahmani, N. and Banaei, M., 2019. Etiology and risk factors associated with infertility. Int J Women’s Health Reprod Sci, 7 (3), pp.346-353.
  10. Masoumi SZ, Parsa P, Darvish N, Mokhtari S, Yavangi M, Roshanaei G. 2015. An epidemiologic survey on the causes of infertility in patients referred to the infertility center in Fatemieh Hospital in Hamadan. Iran J Reprod Med. 2015;13 (8):513 .
  11. Marco Filicori, Nanette Santoro, George R. Merriam, William F. Crowley, Jr., Characterization of the Physiological Pattern of Episodic Gonadotropin Secretion throughout the Human Menstrual Cycle, The Journal of Clinical Endocrinology & Metabolism, Volume 62, Issue 6, 1 June 1986, Pages 1136–1144 , Mehtap Polat, Irem Yarali Ozbek, Sandro C Esteves, Peter Humaidan, Hakan Yarali, The LH surge, and ovulation re-visited: a systematic review and meta-analysis and implications for true natural cycle frozen- thawed embryo transfer, Human Reproduction Update, 2022; dmac012,
  12. Murat Erden, Sezcan Mumusoglu, Suliman, S.O. et al. (2019). Epidemiology of infertility and characteristics of infertile couples requesting assisted reproduction in a low-resource setting in Africa, Sudan. Fertil Res and Pract 5, 7 .
  13. Wang, A., Wang, Y., Wu, F., & Zhu, D. (2017). Assessing predictors for the success of GnRH antagonist protocol in reproductive women in IVF/ICSI - in fresh cycles. Biomedical Reports, 7, 482-486 .
  14. Chen CD, Chiang YT, Yang PK, Chen MJ, Chang CH, Yang YS, et al. Frequency of low serum LH is associated with increased early pregnancy loss in IVF/ICSI cycles. Reprod Biomed Online (2016) 33:449–57. doi: 10.1016/j.rbmo.2016.07.001
  15. Liu, S., Lv, Ys., Han, S. et al. 2022. A novel GnRH antagonist protocol based on LH levels versus traditional flexible GnRH antagonist protocol in PCOS patients undergoing in vitro fertilization: study
  16. Benmachiche A, Benbouhedja S, Zoghmar A, Humaidan P. (2019) Low LH Level on the Day of GnRH Agonist Trigger is Associated With Reduced Ongoing Pregnancy and Live Birth Rates and
  17. Lahoud, R., Al-Jefout, M., Tyler, J., Ryan, J., & Driscoll, G. (2006). A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates. Human Reproduction, 21 (10), 2645– 2649 . Hemsey, G. (2008). Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: Evidence of a threshold effect. Current Medical Research and Opinion, 24 (10), 2785–2793 .
  18. O’Dea, L., O’Brien, F., Currie, K., &
  19. Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, et al. 2018. Transfer of fresh versus frozen embryos in ovulatory women. N Engl J Med.;378 (2):126–36. Endocrine characteristics of assisted reproduction technology cycles. In Gardner DK, Weissman A, Howles CM, Shoham Z. Textbook of Assisted Reproductive Techniques. Volume 2: Clinical Perspectives (pp. 533–542) . AL, Bauer-Dantoin AC, Jameson JL, Weiss J. 1996. Gonadotropin-releasing hormone regulates follicle-stimulating hormone-beta gene expression through an activin/follistatin autocrine or paracrine loop. Endocrinology. ;137:3667–3673.
  20. Urman, B., Ata, B., & Yarali, H. (2018). protocol for a randomized controlled, non- inferiority trial. Trials 23, 654
  21. Besecke LM, Guendner MJ, Schneyer Increased Early Miscarriage Rates Following IVF/ICSI Treatment and Fresh Embryo Transfer. Front Endocrinol 10:639. Doi: 10.3389/fendo.2019.00639
  22. Hendriks ML, Lambalk CB, Helder MN, de Koning J. . 2011. Purification of a candidate gonadotrophin surge- inhibiting/attenuating factor (GnSIF/AF) showing MAPK as a possible target. Mol Reprod Dev;78:292–304 .
  23. Messinis IE, Milingos S, Zikopoulos K, Hasiotis G, Seferiadis K, Lolis D. 1998. Luteinizing hormone response to gonadotrophin-releasing hormone in normal women undergoing ovulation induction with urinary or recombinant follicle stimulating hormone. Hum Reprod. 1998 Sep;13 (9):2415-20. doi: 10.1093/humrep/13.9.2415. PMID: 9806260.
  24. Vega MG, Zarek SM, Bhagwat M, Segars JH. 2015. Gonadotropin surge- inhibiting/attenuating factors: a review of current evidence, potential applications, and future directions for research. Mol Reprod Dev. 2015 Jan;82 (1):2-16. Doi: 10.1002/mrd.22439. Epub 2015 Jan 12. PMID: 25581424; PMCID: PMC4710370
  25. Turkgeldi E. & Ata B. 2021. Premature ovulation: is any risk small enough to take when avoidable? Reprod. Biomed. Online. 2021; 43 (in this issue): 579
  26. Messinis I.E., Messini C.I., Anifandis G., Daponte A. 2021. Exogenous progesterone for LH surge prevention is redundant in ovarian stimulation protocols. Reproductive BioMedicine Online. 42: 694-697
  27. Alzaidi, Z., Yildiz, Ş.M., Saatçi, Ç. et al. The effect of cytokine leukemia-inhibitory factor (LIF) and interleukin-11 (IL-11) gene expression on the primary infertility related to polycystic ovary syndrome, Tubal factor, and Unexplained infertility in Turkish women. Egypt J Med Hum Genet 22, 85 (2021). https://doi.org/10.1186/s43042-021-00201-9